COVID-19 Survivors at Higher Risk for New Behavioral Health Issues
People who survived the first 30 days of SARS-CoV-2 had increased risk for anxiety, depression, stress and adjustment, sleep, and substance use disorders
More Intensive LDL-C Lowering May Cut Recurrent Stroke Risk
More intensive LDL-C-lowering with statin-based therapies linked to reduced risk for recurrent stroke for patients with evidence of atherosclerosis
New Billing Guidelines Do Not Ease Burden of EHR Documentation
Implementation of new guidelines did affect distribution of levels of service billed for evaluation and management patient visits
Bridging Therapy May Be Better for Large Vessel Occlusion Stroke
Better outcomes associated with IV thrombolysis followed by mechanical thrombectomy versus mechanical thrombectomy alone
Poor Outcomes Common With COVID-19, Acute Ischemic Stroke
Factors associated with poor functional outcomes included age older than 60 years, diabetes mellitus, increased NIHSS, LVO
ASA: Endovascular Therapy Studied in Large Ischemic Stroke
Better functional outcomes but more intracranial hemorrhages seen with endovascular therapy plus medical care versus medical care alone
Prior Authorization Impacts Care, Workforce Productivity
AMA urges employers to ask insurers, employees about the impact of prior authorizations
43.3 Percent of Children With Insomnia Have Persistent Trajectory
5.5-fold increased odds of insomnia symptoms worsening into adult insomnia for short-sleeping adolescents
Risk for Parkinson Disease Reduced After Myocardial Infarction
During median follow-up of 21 years, risk reduced for Parkinson disease, secondary parkinsonism after MI
